Phenyl(2-thioxothiazolidin-3-yl)methanone, 97%, 5g

8-Bromo-5-chloro-1,6-naphthyridine, 95.0%, 5g

Pentafluorophenyl methacrylate, 97%, 25g

N-(2,6-Dichloropyridin-4-yl)-2-(4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazine-1-carboxamide, 98%, 10mg

ethyl 4-(2,5-dimethylphenyl)-2-hydroxy-4-oxobut-2-enoate, 95%, 500mg

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride, 95.0%, 25g

2-Methylpiperazine>99.0%(GC)25g

Methyl 2-fluoro-5-(hydroxymethyl)benzoate, 95.0%, 1g

(6-Amino-5-bromopyridin-3-yl)methanol, 95.0%, 5g

1,3,3-Trimethylindolino-6'-nitrobenzopyrylospiran>98.0%(HPLC)(T)1g

HPLC-Säule NUCLEODUR®, C8 Gravity, 3 µm, 250x4 mm, 1 Stück

(1-Aminomethyl-cyclohexyl)-dimethyl-amine dihydrochloride, 95.0%, 5g

Ethyl (1S,5R,6S)-5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate, 95.0%, 100g